MGP and myocardial infarction: The relatively small sample size of our population may have been insufficient to detect differences of biomarkers between groups, or between acute phase and 1–2 months post-MI phase, considering its asymmetric distribution (e.g. RANKL and MGP circulating levels were associated with CAC, but were not significantly increased in MI patients, compared to controls).